• Buy-in from the top is key to cloud transitions AWS exec says

    Computerworld | As the head of Amazon Web Services, Andy Jassy has seen a lot of big organizations start using the public cloud. The biggest indicator of success for a cloud transition is simple, he says: Has the business' senior staff bought into it?

    Jun 22, 2016

  • Federal Oversight Group Has Complaints But Says Yes To CRISPR Trial

    Xconomy | Despite worries about conflict of interest, a National Institutes of Health committee that oversees the use of gene therapy and other cutting edge biomedical technologies voted today to let researchers move ahead with the CRISPR-Cas9 clinical trial.

    Jun 21, 2016

  • Illumina's Flatley speaks of genomic future

    The San Diego Union-Tribune | Illumina's Flatley speaks of genomic future. Longtime CEO stepping down to become chairman, looks for near-universal use of genome sequencing.

    Jun 21, 2016

  • Nvidias new Pascal GPU to supercharge deep learning

    Computerworld | Some of the world's fastest computers use Nvidia's graphics processor for computer vision and complex calculations, and a new GPU will supercharge these applications.

    Jun 20, 2016

  • Building Human Longevity’s Exhaustive Knowledgebase

    Bio-IT World | Best Practices Winner | Despite advances in genomics in the past decade, there are still large portions of the genome that scientists and physicians don’t know how to interpret. Human Longevity Inc. (HLI) wants to fill in those gaps.

    Jun 17, 2016

  • China claims exascale by 2020 three years before U.S.

    Computerworld | China's Tianhe-3 exascale system is set to go live in 2020, three years ahead of the US roadmap. But raw power aside, what might matter most in next-gen systems is how efficiently apps run.

    Jun 17, 2016

  • Rgenix Closes $33 Million Series B Round

    Bio-IT World Rgenix, a cancer therapeutics company developing first-in-class drugs targeting novel cancer pathways, announced a $33 million Series B financing led by Novo A/S and Sofinnova Partners, with participation from existing investors including Partnership Fund for New York City, Alexandria Venture Investments, and Conegliano Ventures LP. The financing will support clinical development of Rgenix’s lead drug candidates, RGX-104 and RGX-202, as well as further development of its therapeutics pipeline.

    Jun 15, 2016

  • NCI Launches GDC

    Bio-IT World The National Cancer Institute's new Genomic Data Commons platform aims to make genomic data publicly available in support of the “moonshot” to cure cancer.

    Jun 15, 2016

  • How iPS cells changed the world

    Nature News & Comment | Induced pluripotent stem cells were supposed to herald a medical revolution. But ten years after their discovery, they are transforming biological research instead.

    Jun 15, 2016

  • Survey Launch on Public Attitudes Toward Genomic Data Sharing

    Bio-IT World  | The Global Alliance for Genomics and Health (GA4GH) and the Wellcome Genome Campus have together launched a video series and survey to explore public attitudes toward genetic data handling.

    Jun 13, 2016